Literature DB >> 1612073

Diabetic ketoacidosis and hyperosmolar coma.

M D Siperstein1.   

Abstract

DKA-hyperosmolar coma is a readily diagnosed and easily treated, potentially catastrophic emergency that regularly occurs in both Type I and Type II diabetics. This review emphasized that diabetic ketoacidosis and hyperosmolar coma can, and very frequently do, occur concurrently, but it is the hyperosmolar state rather than the DKA that is the primary cause of coma and death in this condition. One must therefore vigorously treat the hyperosmolarity and resulting dehydration, especially when total calculated osmolarity exceeds 230 to 240 mOsm/L. The major aim of treatment is to rapidly replace the major water loss that is responsible for this clinical condition and to stimulate glucose metabolism with insulin. The diagnosis of this dangerous condition is relatively simple. The therapy, in most regards, is equally apparent. There are good data demonstrating that the prompt recognition of DKA-hyperosmolar coma and the simple institution of rapid rehydration have continued to reduce the mortality and complications of this potentially disastrous complication of diabetes mellitus.

Entities:  

Mesh:

Year:  1992        PMID: 1612073

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  6 in total

1.  Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion.

Authors:  Howard Zisser; Eyal Dassau; Justin J Lee; Rebecca A Harvey; Wendy Bevier; Francis J Doyle
Journal:  J Diabetes Sci Technol       Date:  2015-04-21

2.  Comparison of measured and calculated osmolality levels.

Authors:  Ezgi Kar; Evin Kocatürk; Zeynep Küskü Kiraz; Bahar Demiryürek; I Özkan Alataş
Journal:  Clin Exp Nephrol       Date:  2020-01-25       Impact factor: 2.801

3.  Hyperosmolality-induced abnormal patterns of calcium mobilization in smooth muscle cells from non-diabetic and diabetic rats.

Authors:  R Wang; Y Liu; R Sauvé; M B Anand-Srivastava
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

4.  Prevalence, etiology, and prognostic significance of upper gastrointestinal hemorrhage in diabetic ketoacidosis.

Authors:  D O Faigel; D C Metz
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

Review 5.  Enteral nutrition in intensive care patients: a practical approach. Working Group on Nutrition and Metabolism, ESICM. European Society of Intensive Care Medicine.

Authors:  P Jolliet; C Pichard; G Biolo; R Chioléro; G Grimble; X Leverve; G Nitenberg; I Novak; M Planas; J C Preiser; E Roth; A M Schols; J Wernerman
Journal:  Intensive Care Med       Date:  1998-08       Impact factor: 17.440

Review 6.  Beta-glucans in the treatment of diabetes and associated cardiovascular risks.

Authors:  Jiezhong Chen; Kenneth Raymond
Journal:  Vasc Health Risk Manag       Date:  2008
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.